RIGEL PHARMACEUTICALS INC Earnings Per Share Diluted

• RIGEL PHARMACEUTICALS INC showed an increase of +1,867.7% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from RIGEL PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2009 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $0.51 per share | Q3 2010: $0.96 per share | Q2 2011: $0.37 (loss) per share | Q3 2011: $0.25 (loss) per share | Q2 2012: $0.35 (loss) per share | Q3 2012: $0.36 (loss) per share | Q1 2019: $0.11 (loss) per share | Q1 2020: $0.13 per share | Q2 2020: $0.10 (loss) per share | Q3 2020: $0.08 (loss) per share | Q1 2021: $0.22 per share | Q2 2021: $0.08 (loss) per share | Q3 2021: $0.12 (loss) per share | Q1 2022: $0.16 (loss) per share | Q2 2022: $0.08 (loss) per share | Q3 2022: $0.11 (loss) per share | Q1 2023: $0.08 (loss) per share | Q2 2023: $0.38 (loss) per share | Q3 2023: $0.33 (loss) per share | Q1 2024: $0.47 (loss) per share | Q2 2024: $0.06 (loss) per share | Q3 2024: $0.70 per share | Q1 2025: $0.63 per share | Q2 2025: $3.28 per share | Q3 2025: $1.46 per share.
• Over the full 11 years of available data (2009 to 2025), RIGEL PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 813.6%.
• Historical annual values: Fiscal year 2025: $19.48 per share | Fiscal year 2024: $0.99 per share | Fiscal year 2023: $1.44 (loss) per share | Fiscal year 2022: $3.44 (loss) per share | Fiscal year 2021: $0.11 (loss) per share | Fiscal year 2020: $0.18 (loss) per share | Fiscal year 2019: $0.40 (loss) per share | Fiscal year 2012: $1.32 (loss) per share | Fiscal year 2011: $1.36 (loss) per share | Fiscal year 2010: $0.72 per share | Fiscal year 2009: $2.73 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026